CELANO MICHAEL (Chief Financial Officer) received a stock award from LARIMAR THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/27/2026ACC: 0001193125-26-024824
Officer· Chief Financial Officer
Since May 2020
+263.23K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
263.23K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+37.60K
Price / share
—
Trade value
—
% of position
21.1%
1/26/2026
178.18K→215.78K
Total
Net shares
+37.60K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/26/2026 | A · Award | +37.60K | — | — | 21.1% | 178.18K | 215.78K |
| Total | +37.60K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
225.62K shares
Shares
+225.62K
Strike price
3.60
Held after
225.62K
Exercisable
—
1/26/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock225.62K shares | 1/26/2026 | A · Award | +225.62K | 3.60 | — | 225.62K |